Reason for request
Inclusion on the list of medicines reimbursed by National Insurance and approved for use by hospitals.
Clinical Benefit
| Moderate |
Le service médical rendu par DICLOFENAC MIKA PHARMA 4% est modéré.
|
Clinical Added Value
| no clinical added value |
La spécialité Diclofénac Mika Pharma 4% n’apporte pas d’amélioration du service médical rendu (ASMR V) par rapport aux autres AINS topiques.
|
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
rgHxQ2FxB2Pr3bV2
Listen
